5-Amino-1MQ dosage: why there is no validated human dose

There is a clean way to write a dosage page when a compound has been through human trials: you report what the trials gave people. 5-Amino-1MQ does not allow that, and pretending otherwise would be dishonest. The entire usable record is preclinical, so this page is less a dosing guide than an explanation of why no trustworthy dose exists. For what the molecule is and what the animal work actually showed, read the 5-Amino-1MQ evidence monograph first.

There is no established human dose

Start with the part that the marketing tends to bury: no human has been given 5-Amino-1MQ in a registered clinical trial, so there is no human efficacy data, no human safety data, and no published human pharmacokinetics.^[1] A dose only earns the word “established” once a study has shown what amount produces an effect in people without unacceptable harm. None of that work has happened here. Whatever number a seller prints on a label, it rests on inference, not on a result.

What the animal studies actually dosed

The figures that do exist come from rodents, and they are reported the way pharmacology reports animal doses: in milligrams per kilogram of body weight, not as a fixed capsule. The obesity-reversal study dosed diet-induced obese mice with an NNMT inhibitor and tracked body composition; a 2024 follow-up gave obese mice 5-Amino-1MQ once daily for 28 days and found that the benefits on weight, glucose tolerance, and fatty liver were dose-dependent — more compound, more effect, within the range tested.^[2] That is a meaningful pharmacological signal. It is not a human prescription.

Why a mouse mg/kg number does not become a human dose

It is tempting to take a mouse’s mg/kg figure, multiply by a human’s body weight, and call the result a dose. That arithmetic is wrong. Drugs are absorbed, distributed, metabolized, and cleared at very different rates across species, and rodents generally run faster metabolisms that demand proportionally higher mg/kg amounts than people. The only published pharmacokinetics for this molecule are in rats — a study measuring its plasma levels and oral bioavailability — and the 2024 mouse work likewise characterized plasma and tissue exposure across intravenous, oral, and subcutaneous routes.^[2][3]Useful as those are for animal modelling, neither tells you the milligrams a human would need, because the human exposure-to-dose relationship has never been measured.

The route: oral, by design

One detail the chemistry settles cleanly is the route. 5-Amino-1MQ was deliberately engineered as a small, membrane-permeable molecule, which is why it can be taken by mouth rather than injected like most of the peptides covered on this site.^[4] The rat pharmacokinetic work was explicitly aimed at oral bioavailability, and the mouse study confirmed systemic exposure after oral dosing.^[2][3]So the products sold are oral capsules — but an oral route being plausible is not the same as an oral dose being known. Knowing how a drug gets in does not tell you how much to put in.

Unknown long-term safety

The short rodent studies reported no obvious adverse effects, but “no harm seen in mice over a few weeks” is a narrow claim.^[1] NNMT sits at a metabolic crossroads, and chronically inhibiting it in a person could have consequences that a 28-day mouse experiment was never built to detect.^[2] Without longer-term human data — the kind only trials produce — the long-term safety of any sustained dose is genuinely unknown, not merely uncharacterized.

The honest bottom line

If you reduce 5-Amino-1MQ dosing to what the evidence supports, the answer is uncomfortable but simple: there is no validated human dose. The only real numbers are rodent mg/kg figures that do not convert to people, the route is oral but the amount is unknown, and the capsule ranges sold online are self-experimentation with an untested compound.^[1][2] Anyone considering it should treat that uncertainty as the headline, not a footnote, and any decision belongs with a clinician who can supervise an experimental compound — not with a vendor’s suggested-use box. For metabolic compounds that actually have human dosing data, see our weight-loss evidence roundup.